Search research articles
Contact Us
Filters
Showing results (1-10 of 58) with videos related to
Page
of 6
Sort By:
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
July 26, 2017
[Current Clinical Assessment Scales and Cognitive Tests in Global Clinical Studies on Alzheimer's Disease]
Ryoko Ihara
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 31, 2016
[New diagnostic guidelines for Alzheimer's disease by NIA/AA]
Ryoko Ihara
The Journal of Prevention of Alzheimer'S Disease
|
April 19, 2026
Cost analyses of plasma p-tau217 versus p-tau217/Aβ42 ratio using two-step approach in the Japanese health care system
Masanori Kurihara, Ryoko Ihara, Kenichiro Sato, et al.
Journal of Alzheimer'S Disease Reports
|
December 25, 2025
National trends in cerebrospinal fluid biomarker testing for Alzheimer's disease in Japan
Masanori Kurihara, Ryoko Ihara, Kenichiro Sato, et al.
Journal of Alzheimer'S Disease Reports
|
September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation study
Kenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Clinical Nuclear Medicine
|
July 24, 2024
Clinical Application of 18 F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C
Soichiro Kondo, Kenji Ishibashi, Kenji Ishii, et al.
Biomedicines
|
August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life
|
July 30, 2025
How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodies
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2025
Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 58) with videos related to
Sort By:
Page
of 6
Brain and Nerve = Shinkei Kenkyu No Shinpo
|
July 26, 2017
[Current Clinical Assessment Scales and Cognitive Tests in Global Clinical Studies on Alzheimer's Disease]
Ryoko Ihara
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
March 31, 2016
[New diagnostic guidelines for Alzheimer's disease by NIA/AA]
Ryoko Ihara
The Journal of Prevention of Alzheimer'S Disease
|
April 19, 2026
Cost analyses of plasma p-tau217 versus p-tau217/Aβ42 ratio using two-step approach in the Japanese health care system
Masanori Kurihara, Ryoko Ihara, Kenichiro Sato, et al.
Journal of Alzheimer'S Disease Reports
|
December 25, 2025
National trends in cerebrospinal fluid biomarker testing for Alzheimer's disease in Japan
Masanori Kurihara, Ryoko Ihara, Kenichiro Sato, et al.
Journal of Alzheimer'S Disease Reports
|
September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation study
Kenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Clinical Nuclear Medicine
|
July 24, 2024
Clinical Application of 18 F-THK5351 PET to Image Ongoing Astrogliosis in MSA-P and MSA-C
Soichiro Kondo, Kenji Ishibashi, Kenji Ishii, et al.
Biomedicines
|
August 29, 2024
Regional Variability in MRI Scans with Different Magnetic Field Strengths in Japan: Implications for Healthcare Preparedness for Alzheimer's Disease Treatment
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD
|
September 13, 2024
Adverse Events as a Cause of Unblinding of Allocated Arms in Anti-Amyloid Therapy Trials: A Meta-Analysis of the Predictive Value
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life
|
July 30, 2025
How many sites are enough? a novel, site-based power analysis method for real-world registry studies of anti-amyloid monoclonal antibodies
Kenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease Reports
|
June 11, 2025
Audio review as a measure of quality assurance and control of cognitive assessments in Alzheimer's disease studies: An experience from Japanese Trial-Ready Cohort Study
Kenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Page
of 6